Видео ютуба по тегу Aurobindo Pharma Revenue

Aurobindo Pharma Q1FY26 Earnings Concall
Aurobindo Pharma Q1FY26 Earnings Concall
Aurobindo Pharma’s Growth Engines: CFO S. Subramanian On FY26 Strategy
Aurobindo Pharma’s Growth Engines: CFO S. Subramanian On FY26 Strategy
Inside Aurobindo Pharma’s Next Big Leap: Capex Pause, ROE Push & New Growth Engines Explained!
Inside Aurobindo Pharma’s Next Big Leap: Capex Pause, ROE Push & New Growth Engines Explained!
Aurobindo Pharma Limited (AUROPHARMA) Q4 2025 Earnings – Full Coverage
Aurobindo Pharma Limited (AUROPHARMA) Q4 2025 Earnings – Full Coverage
Aurobindo Pharma Issues Clarification Over Buyout Reports 'Premature' | Watch | Business News
Aurobindo Pharma Issues Clarification Over Buyout Reports 'Premature' | Watch | Business News
Aurobindo Pharma - A wealth compounder in the making? Find out why we like this company!
Aurobindo Pharma - A wealth compounder in the making? Find out why we like this company!
Aurobindo Pharma Announces Entry Into The Domestic Formulations Business
Aurobindo Pharma Announces Entry Into The Domestic Formulations Business
Aurobindo Pharma Earnings Call for Q4FY21
Aurobindo Pharma Earnings Call for Q4FY21
Aurobindo Pharma Earnings call Q3 FY 24 | 10-FEB-24
Aurobindo Pharma Earnings call Q3 FY 24 | 10-FEB-24
Aurobindo Pharma Income Statement Analysis | Sales 4X | But Stock Down -31%
Aurobindo Pharma Income Statement Analysis | Sales 4X | But Stock Down -31%
Aurobindo Pharma Earnings Call for Q4FY20 and Full Year
Aurobindo Pharma Earnings Call for Q4FY20 and Full Year
Aurobindo Pharma’s Next Big Leap: Merck-CDMO Boost, US Capacity Ramp-Up & FDA Timeline | ET Now
Aurobindo Pharma’s Next Big Leap: Merck-CDMO Boost, US Capacity Ramp-Up & FDA Timeline | ET Now
Aurobindo Pharma Stock Under Pressure As Company Is Frontrunner To Buy Zentiva | CNBC TV18
Aurobindo Pharma Stock Under Pressure As Company Is Frontrunner To Buy Zentiva | CNBC TV18
Aurobindo Pharma To Buy Lannet For $250 M, Acquisition To Add $300 M To Aurobindo's Topline
Aurobindo Pharma To Buy Lannet For $250 M, Acquisition To Add $300 M To Aurobindo's Topline
Aurobindo Pharma Q2FY21 Review- Better than estimates?
Aurobindo Pharma Q2FY21 Review- Better than estimates?
Aurobindo Pharma Q1 Results || Aurobindo Pharma Results Today || Aurobindo Pharma Latest news
Aurobindo Pharma Q1 Results || Aurobindo Pharma Results Today || Aurobindo Pharma Latest news
Bharat Forge, Dr Reddy’s, Cyient и Aurobindo Pharma бурно развиваются на фоне возобновления торго...
Bharat Forge, Dr Reddy’s, Cyient и Aurobindo Pharma бурно развиваются на фоне возобновления торго...
AUROBINDO PHARMA LTD Q4 FY22 Earnings Concall
AUROBINDO PHARMA LTD Q4 FY22 Earnings Concall
Aurobindo Pharma Q1. Total Income Rises 12.9%
Aurobindo Pharma Q1. Total Income Rises 12.9%
Aurobindo Pharma Slips In Trade After CNBC-TV18 Accesses US FDA Observations For Unit 12
Aurobindo Pharma Slips In Trade After CNBC-TV18 Accesses US FDA Observations For Unit 12
'Big Bull' Rakesh Jhunjhunwala Questions Aurobindo Pharma's Management
'Big Bull' Rakesh Jhunjhunwala Questions Aurobindo Pharma's Management